Actively Recruiting
Phase 12 Study to Evaluate Safety and Effectiveness of Autologous Dermal Fibroblast Clusters for Treating Wrinkles Around Both Eyes
Led by S.Biomedics Co., Ltd. · Updated on 2025-05-18
80
Participants Needed
1
Research Sites
51 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and effectiveness of injecting clusters of a persons own skin cells called autologous dermal fibroblasts to treat wrinkles around the eyes, known as bilateral crows feet. This phase 12 clinical trial first assesses safety in a small group and then tests how well the treatment works, using a randomized, placebo-controlled design. The study is conducted by S.Biomedics Co., Ltd. and is focused on adults aged 19 and older with moderate periorbital wrinkles. Participants receive a single dose of the study treatment or a placebo, injected into three spots around each eye along the wrinkles. The dose contains 1 x 107 cells per 1 mL vial for the active treatment group, while the placebo group receives an injection without these cells. The trial has two phases phase 1 to check safety and phase 2 to assess wrinkle improvement and safety over 24 weeks, with evaluations at 2, 12, and 24 weeks post-injection. During the study, participants visit the site six times, including screening and follow-ups. Safety is monitored at every visit, and wrinkle severity is measured using a specific scale called the IGA-LCL Wrinkle Severity. Participants agree to stop other skin treatments and undergo blood tests and skin checks before joining. The study tracks improvements in wrinkles and any adverse effects up to 24 weeks after treatment.
CONDITIONS
Brief Title
A Study on the Anti-Wrinkle Efficacy Assessment and Safety Evaluation of the Cluster of Autologous Dermal Fibroblast on Bilateral Crow's Feet
Research Team
S
Sarang Kim, Master's
J
Jong-Wan Kim, Master's
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here